Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Development and characterisation of thermo reversible mucoadhesive moxifloxacin hydrochloride in situ ophthalmic gel.

Dholakia M, Thakkar V, Patel N, Gandhi T.

J Pharm Bioallied Sci. 2012 Mar;4(Suppl 1):S42-5. doi: 10.4103/0975-7406.94138.

2.

Studies on Poloxamer Based Mucoadhesive Insitu Ophthalmic Hydrogel of Moxifloxacin HCL.

Shastri DH, Prajapati ST, Patel LD.

Curr Drug Deliv. 2010 Feb 17. [Epub ahead of print]

PMID:
20158483
3.

Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride.

Mandal S, Thimmasetty MK, Prabhushankar G, Geetha M.

Int J Pharm Investig. 2012 Apr;2(2):78-82. doi: 10.4103/2230-973X.100042.

4.

Formulation and evaluation of in situ gelling thermoreversible mucoadhesive gel of fluconazole.

Gonjari ID, Hosmani AH, Karmarkar AB, Godage AS, Kadam SB, Dhabale PN.

Drug Discov Ther. 2009 Feb;3(1):6-9.

5.

Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl.

Shastri DH, Prajapati ST, Patel LD.

Curr Drug Deliv. 2010 Jul;7(3):238-43.

PMID:
20497100
6.
7.

Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide.

Yuan Y, Cui Y, Zhang L, Zhu HP, Guo YS, Zhong B, Hu X, Zhang L, Wang XH, Chen L.

Int J Pharm. 2012 Jul 1;430(1-2):114-9. doi: 10.1016/j.ijpharm.2012.03.054. Epub 2012 Apr 5.

PMID:
22503953
8.

Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride.

Makwana SB, Patel VA, Parmar SJ.

Results Pharma Sci. 2015 Jul 8;6:1-6. doi: 10.1016/j.rinphs.2015.06.001. eCollection 2016.

9.

Thermoreversible nasal in situ gel of venlafaxine hydrochloride: formulation, characterization, and pharmacodynamic evaluation.

Bhandwalkar MJ, Avachat AM.

AAPS PharmSciTech. 2013 Mar;14(1):101-10. doi: 10.1208/s12249-012-9893-1. Epub 2012 Dec 11.

10.
11.

Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.

M A Fathalla Z, Vangala A, Longman M, Khaled KA, Hussein AK, El-Garhy OH, Alany RG.

Eur J Pharm Biopharm. 2017 May;114:119-134. doi: 10.1016/j.ejpb.2017.01.008. Epub 2017 Jan 24.

PMID:
28126392
12.

Thermoreversible mucoadhesive ophthalmic in situ hydrogel: Design and optimization using a combination of polymers.

Shastri DH, Prajapati ST, Patel LD.

Acta Pharm. 2010 Sep;60(3):349-60. doi: 10.2478/v10007-010-0029-4.

PMID:
21134868
13.

A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery.

Gratieri T, Gelfuso GM, Rocha EM, Sarmento VH, de Freitas O, Lopez RF.

Eur J Pharm Biopharm. 2010 Jun;75(2):186-93. doi: 10.1016/j.ejpb.2010.02.011. Epub 2010 Feb 25.

PMID:
20188828
14.

Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.

AltuntaƟ E, Yener G.

AAPS PharmSciTech. 2017 Oct;18(7):2673-2682. doi: 10.1208/s12249-017-0747-8. Epub 2017 Mar 9.

PMID:
28281209
15.

A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.

Mayol L, Quaglia F, Borzacchiello A, Ambrosio L, La Rotonda MI.

Eur J Pharm Biopharm. 2008 Sep;70(1):199-206. doi: 10.1016/j.ejpb.2008.04.025. Epub 2008 May 9.

PMID:
18644705
16.

Studies on In situ Hydrogel: A Smart Way for Safe and Sustained Ocular Drug Delivery.

Shastri D, Patel L, Parikh R.

J Young Pharm. 2010 Apr;2(2):116-20. doi: 10.4103/0975-1483.63144.

17.
18.
19.
20.

Development and evaluation of aceclofenac-loaded mucoadhesive microcapsules.

Mankala SK, Korla AC, Gade S.

J Adv Pharm Technol Res. 2011 Oct;2(4):245-54. doi: 10.4103/2231-4040.90881.

Supplemental Content

Support Center